Mausner LF - Search Results

1

Mirzadeh S, Mausner LF, Srivastava SC. Mirzadeh S, et al. Among authors: mausner lf. Int J Rad Appl Instrum A. 1986;37(1):29-36. doi: 10.1016/0883-2889(86)90192-9. Int J Rad Appl Instrum A. 1986. PMID: 3019924

2

Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy.

Kolsky KL, Joshi V, Mausner LF, Srivastava SC. Kolsky KL, et al. Among authors: mausner lf. Appl Radiat Isot. 1998 Dec;49(12):1541-9. doi: 10.1016/s0969-8043(98)00016-5. Appl Radiat Isot. 1998. PMID: 9745690

3

Development of a large scale production of 67Cu from 68Zn at the high energy proton accelerator: closing the 68Zn cycle.

Medvedev DG, Mausner LF, Meinken GE, Kurczak SO, Schnakenberg H, Dodge CJ, Korach EM, Srivastava SC. Medvedev DG, et al. Among authors: mausner lf. Appl Radiat Isot. 2012 Mar;70(3):423-9. doi: 10.1016/j.apradiso.2011.10.007. Epub 2011 Oct 20. Appl Radiat Isot. 2012. PMID: 22142633

4

Radioactive gold cluster immunoconjugates: potential agents for cancer therapy.

Hainfeld JF, Foley CJ, Srivastava SC, Mausner LF, Feng NI, Meinken GE, Steplewski Z. Hainfeld JF, et al. Among authors: mausner lf. Int J Rad Appl Instrum B. 1990;17(3):287-94. doi: 10.1016/0883-2897(90)90054-5. Int J Rad Appl Instrum B. 1990. PMID: 2341283

5

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.

Denardo GL, Denardo SJ, Kukis DL, O'Donnell RT, Shen S, Goldstein DS, Kroger LA, Salako Q, Denardo DA, Mirick GR, Mausner LF, Srivastava SC, Meares CF. Denardo GL, et al. Among authors: mausner lf. Anticancer Res. 1998 Jul-Aug;18(4B):2779-88. Anticancer Res. 1998. PMID: 9713461 Clinical Trial.

6

67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.

DeNardo SJ, DeNardo GL, Kukis DL, Shen S, Kroger LA, DeNardo DA, Goldstein DS, Mirick GR, Salako Q, Mausner LF, Srivastava SC, Meares CF. DeNardo SJ, et al. Among authors: mausner lf. J Nucl Med. 1999 Feb;40(2):302-10. J Nucl Med. 1999. PMID: 10025839 Free article.

7

Radionuclide development at BNL for nuclear medicine therapy.

Mausner LF, Kolsky KL, Joshi V, Srivastava SC. Mausner LF, et al. Appl Radiat Isot. 1998 Apr;49(4):285-94. doi: 10.1016/s0969-8043(97)00040-7. Appl Radiat Isot. 1998. PMID: 9519438 Review.

8

Selection of radionuclides for radioimmunotherapy.

Mausner LF, Srivastava SC. Mausner LF, et al. Med Phys. 1993 Mar-Apr;20(2 Pt 2):503-9. doi: 10.1118/1.597045. Med Phys. 1993. PMID: 8492758 Review. No abstract available.

9

Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2.

DeNardo GL, Kukis DL, DeNardo SJ, Shen S, Mausner LF, O'Donnell RT, Lamborn KR, Meyers FJ, Srivastava SC, Miers LA. DeNardo GL, et al. Among authors: mausner lf. Cancer. 1997 Dec 15;80(12 Suppl):2576-82. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2576::aid-cncr33>3.3.co;2-3. Cancer. 1997. PMID: 9406712

10

Production of Sn-117m in the BR2 high-flux reactor.

Ponsard B, Srivastava SC, Mausner LF, Russ Knapp FF, Garland MA, Mirzadeh S. Ponsard B, et al. Among authors: mausner lf. Appl Radiat Isot. 2009 Jul-Aug;67(7-8):1158-61. doi: 10.1016/j.apradiso.2009.02.023. Epub 2009 Feb 20. Appl Radiat Isot. 2009. PMID: 19303313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters